1,473
Views
62
CrossRef citations to date
0
Altmetric
Original

RENAL FUNCTION AND STRUCTURE IN DIABETIC, HYPERTENSIVE, OBESE ZDFxSHHF-HYBRID RATS

, , &
Pages 387-406 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Shitalkumar P Zambad, Siralee Munshi, Amita Dubey, Ram Gupta, Rosa Anna Busiello, Antonia Lanni, Fernando Goglia, Ramesh C Gupta, Vijay Chauthaiwale & Chaitanya Dutt. (2011) TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats. Diabetes, Metabolic Syndrome and Obesity 4, pages 5-16.
Read now
Eyup Koc, Murat Suher & Gulden Bayrak. (2006) Effects of Anthropometric Measurements on Renal Function. Renal Failure 28:8, pages 737-741.
Read now
Stevan P. Tofovic, Hideaki Kusaka, Edwin K. Jackson & Sheldon I. Bastacky. (2001) RENAL AND METABOLIC EFFECTS OF CAFFEINE IN OBESE (fa/facp), DIABETIC, HYPERTENSIVE ZSF1 RATS*. Renal Failure 23:2, pages 159-173.
Read now

Articles from other publishers (59)

Ju Wang, Agustin Casimiro-Garcia, Bryce G. Johnson, Jennifer Duffen, Michael Cain, Leigh Savary, Stephen Wang, Prashant Nambiar, Matthew Lech, Shanrong Zhao, Li Xi, Yutian Zhan, Jennifer Olson, James A. Stejskal, Hank Lin, Baohong Zhang, Robert V. Martinez, Katherine Masek-Hammerman, Franklin J. Schlerman & Ken Dower. (2023) A protein kinase C α and β inhibitor blunts hyperphagia to halt renal function decline and reduces adiposity in a rat model of obesity-driven type 2 diabetes. Scientific Reports 13:1.
Crossref
Charles Duncan Smart & Meena S. Madhur. (2023) The immunology of heart failure with preserved ejection fraction. Clinical Science 137:16, pages 1225-1247.
Crossref
Jan R. Kraehling, Agnes Benardeau, Tibor Schomber, Laura Popp, Julia Vienenkoetter, Heidrun Ellinger-Ziegelbauer, Mira Pavkovic, Elke Hartmann, Krystyna Siudak, Alexius Freyberger, Ina Hagelschuer, Ilka Mathar, Joerg Hueser, Michael G. Hahn, Volker Geiss, Frank Eitner & Peter Sandner. (2023) The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 Rats. International Journal of Molecular Sciences 24:17, pages 13226.
Crossref
Dira Ummul Azizah, Anton Bahtiar & MARISSA ANGELINA. (2023) ANIMAL MODELS OF DIABETIC NEPHROPATHY. Asian Journal of Pharmaceutical and Clinical Research, pages 11-23.
Crossref
Michael S. Balzer, Mira Pavkovic, Julia Frederick, Amin Abedini, Alexius Freyberger, Julia Vienenkötter, Ilka Mathar, Krystyna Siudak, Frank Eitner, Peter Sandner, Manuel Grundmann & Katalin Susztak. (2023) Treatment effects of soluble guanylate cyclase modulation on diabetic kidney disease at single-cell resolution. Cell Reports Medicine 4:4, pages 100992.
Crossref
Isabel T.N. Nguyen, Jaap A. Joles, Marianne C. Verhaar, Hildo J. Lamb & Ilona A. Dekkers. 2023. Visceral and Ectopic Fat. Visceral and Ectopic Fat 243 264 .
Jolanda van der Velden, Folkert W Asselbergs, Jeroen Bakkers, Sandor Batkai, Luc Bertrand, Connie R Bezzina, Ilze Bot, Bianca J J M Brundel, Lucie Carrier, Steven Chamuleau, Michele Ciccarelli, Dana Dawson, Sean M Davidson, Andreas Dendorfer, Dirk J Duncker, Thomas Eschenhagen, Larissa Fabritz, Ines Falcão-Pires, Péter Ferdinandy, Mauro Giacca, Henrique Girao, Can Gollmann-Tepeköylü, Mariann Gyongyosi, Tomasz J Guzik, Nazha Hamdani, Stephane Heymans, Andres Hilfiker, Denise Hilfiker-Kleiner, Alfons G Hoekstra, Jean-Sébastien Hulot, Diederik W D Kuster, Linda W van Laake, Sandrine Lecour, Tim Leiner, Wolfgang A Linke, Joost Lumens, Esther Lutgens, Rosalinda Madonna, Lars Maegdefessel, Manuel Mayr, Peter van der Meer, Robert Passier, Filippo Perbellini, Cinzia Perrino, Maurizio Pesce, Silvia Priori, Carol Ann Remme, Bodo Rosenhahn, Ulrich Schotten, Rainer Schulz, Karin R Sipido, Joost P G Sluijter, Frank van Steenbeek, Sabine Steffens, Cesare M Terracciano, Carlo Gabriele Tocchetti, Patricia Vlasman, Kak Khee Yeung, Serena Zacchigna, Dayenne Zwaagman & Thomas Thum. (2022) Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart. Cardiovascular Research 118:15, pages 3016-3051.
Crossref
Magdalena Jasińska-Stroschein. (2022) Searching for an experimental rodent model of heart failure with preserved ejection fraction: Re-visited. Biomedicine & Pharmacotherapy 152, pages 113251.
Crossref
Jason Roh, Joseph A. Hill, Abhilasha Singh, María Valero-Muñoz & Flora Sam. (2022) Heart Failure With Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models. Circulation Research 130:12, pages 1906-1925.
Crossref
Barbara Petzuch, Agnès Bénardeau, Lucas Hofmeister, Jutta Meyer, Elke Hartmann, Mira Pavkovic, Ilka Mathar, Peter Sandner & Heidrun Ellinger-Ziegelbauer. (2022) Urinary miRNA Profiles in Chronic Kidney Injury—Benefits of Extracellular Vesicle Enrichment and miRNAs as Potential Biomarkers for Renal Fibrosis, Glomerular Injury, and Endothelial Dysfunction. Toxicological Sciences 187:1, pages 35-50.
Crossref
Pierre E. Signore, Guangjie Guo, Zhihua Wei, Weihua Zhang, Al Lin & Ughetta del Balzo. (2021) A small-molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase improves obesity, nephropathy and cardiomyopathy in obese ZSF1 rats. PLOS ONE 16:8, pages e0255022.
Crossref
Jessica L. Faulkner. (2021) Obesity-associated cardiovascular risk in women: hypertension and heart failure. Clinical Science 135:12, pages 1523-1544.
Crossref
Sumita Mishra & David A. Kass. (2021) Cellular and molecular pathobiology of heart failure with preserved ejection fraction. Nature Reviews Cardiology 18:6, pages 400-423.
Crossref
Zita Wachal, Anna Szilágyi, Barbara Takács, Adrienn Mónika Szabó, Dániel Priksz, Mariann Bombicz, Judit Szilvássy, Béla Juhász, Zoltán Szilvássy & Balázs Varga. (2021) Improved Survival and Retinal Function of Aging ZDF Rats in Long-Term, Uncontrolled Diabetes by BGP-15 Treatment. Frontiers in Pharmacology 12.
Crossref
Sin-Hee Park, Muhammad Akmal Farooq, Sébastien Gaertner, Christophe Bruckert, Abdul Wahid Qureshi, Hyun-Ho Lee, Djamel Benrahla, Brigitte Pollet, Dominique Stephan, Patrick Ohlmann, Jean-Marc Lessinger, Eric Mayoux, Cyril Auger, Olivier Morel & Valérie B. Schini-Kerth. (2020) Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat. Cardiovascular Diabetology 19:1.
Crossref
Marina Stolina, Xin Luo, Denise Dwyer, Chun-Ya Han, Rhonda Chen, Ying Zhang, YuMei Xiong, Yinhong Chen, Jun Yin, Artem Shkumatov, Brandon Ason, Clarence Hale & Murielle M. Véniant. (2020) The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15. PLOS ONE 15:8, pages e0231234.
Crossref
Longfei WangGunner Halliday, Joshua R. Huot, Taijyu SatohJeffrey J. Baust, Amanda Fisher, Todd Cook, Jian Hu, Theodore Avolio, Dmitry A. Goncharov, Yang Bai, Rebecca R. VanderpoolRobert V. Considine, Andrea Bonetto, Jiangning Tan, Timothy N. Bachman, Andrea Sebastiani, Charles F. McTiernan, Ana L. Mora, Roberto F. Machado, Elena A. Goncharova, Mark T. Gladwin & Yen-Chun Lai. (2020) Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction. Arteriosclerosis, Thrombosis, and Vascular Biology 40:6, pages 1543-1558.
Crossref
Daniel P. Zimmer, Courtney M. Shea, Jenny V. Tobin, Boris Tchernychev, Peter Germano, Kristie Sykes, Ali R. Banijamali, Sarah Jacobson, Sylvie G. Bernier, Renee Sarno, Andrew Carvalho, Yueh-tyng Chien, Regina Graul, Emmanuel S. Buys, Juli E. Jones, James D. Wakefield, Gavrielle M. Price, Jennifer G. Chickering, G. Todd Milne, Mark G. Currie & Jaime L. Masferrer. (2020) Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease. Frontiers in Pharmacology 11.
Crossref
Inês Preguiça, André Alves, Sara Nunes, Pedro Gomes, Rosa Fernandes, Sofia D. Viana & Flávio Reis. (2020) Diet-Induced Rodent Models of Diabetic Peripheral Neuropathy, Retinopathy and Nephropathy. Nutrients 12:1, pages 250.
Crossref
Kasi C. McPherson, Corbin A. Shields, Bibek Poudel, Brianca Fizer, Alyssa Pennington, Ashley Szabo-Johnson, Willie L. Thompson, Denise C. Cornelius & Jan M. Williams. (2019) Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity. American Journal of Physiology-Renal Physiology 316:2, pages F316-F327.
Crossref
Yen‐Chun Lai, Longfei Wang & Mark T. Gladwin. (2018) Insights into the pulmonary vascular complications of heart failure with preserved ejection fraction. The Journal of Physiology 597:4, pages 1143-1156.
Crossref
Isabel Nguyen, Arianne van Koppen & Jaap A. Joles. 2019. Diabetic Nephropathy. Diabetic Nephropathy 375 413 .
Bruce L. Homer & Ken Dower. (2018) 41-Week Study of Progressive Diabetic Nephropathy in the ZSF1 fa/fa CP Rat Model . Toxicologic Pathology 46:8, pages 976-977.
Crossref
Bo La Han, Qiunong Guan, Irina Chafeeva, Asher A. Mendelson, Gerald da Roza, Richard Liggins, Jayachandran N. Kizhakkedathu & Caigan Du. (2018) Peritoneal and Systemic Responses of Obese Type II Diabetic Rats to Chronic Exposure to a Hyperbranched Polyglycerol-Based Dialysis Solution. Basic & Clinical Pharmacology & Toxicology 123:4, pages 494-503.
Crossref
Zhi Su, Deborah Widomski, Arthur Nikkel, Laura Leys, Marian Namovic, Diana Donnelly-Roberts, Murali Gopalakrishnan & Steve McGaraughty. (2018) Losartan improves renal function and pathology in obese ZSF-1 rats. Journal of Basic and Clinical Physiology and Pharmacology 29:3, pages 281-290.
Crossref
Eman M. Salah, Sheldon I. Bastacky, Edwin K. Jackson & Stevan P. Tofovic. (2018) Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction. Journal of Cardiovascular Pharmacology 71:4, pages 205-214.
Crossref
Maria Valero-Muñoz, Warren Backman & Flora Sam. (2017) Murine Models of Heart Failure With Preserved Ejection Fraction. JACC: Basic to Translational Science 2:6, pages 770-789.
Crossref
Xiaoyan Zhou, Ji Zhang, Robin Haimbach, Wei Zhu, Rosemary Mayer-Ezell, Margarita Garcia-Calvo, Elizabeth Smith, Olga Price, Yanqing Kan, Emanuel Zycband, Yonghua Zhu, Maarten Hoek, Jason M. Cox, Lijun Ma, David E. Kelley & Shirly Pinto. (2017) An integrin antagonist (MK-0429) decreases proteinuria and renal fibrosis in the ZSF1 rat diabetic nephropathy model. Pharmacology Research & Perspectives 5:5, pages e00354.
Crossref
Ken Dower, Shanrong Zhao, Franklin J. Schlerman, Leigh Savary, Gabriela Campanholle, Bryce G. Johnson, Li Xi, Vuong Nguyen, Yutian Zhan, Matthew P. Lech, Ju Wang, Qing Nie, Morten A. Karsdal, Federica Genovese, Germaine Boucher, Thomas P. Brown, Baohong Zhang, Bruce L. Homer & Robert V. Martinez. (2017) High resolution molecular and histological analysis of renal disease progression in ZSF1 fa/faCP rats, a model of type 2 diabetic nephropathy. PLOS ONE 12:7, pages e0181861.
Crossref
Salwa Almomen, Qiunong Guan, Peihe Liang, Kaidi Yang, Ahmad Sidiqi, Adeera Levin & Caigan Du. (2017) Daily Intake of Grape Powder Prevents the Progression of Kidney Disease in Obese Type 2 Diabetic ZSF1 Rats. Nutrients 9:4, pages 345.
Crossref
Marta Borges Canha, José Pedro Portela-Cidade, Glória Conceição, Cláudia Sousa-Mendes, Sara Leite, Dulce Fontoura, Daniel Moreira-Gonçalves, Inês Falcão-Pires, André Lourenço, Adelino Leite-Moreira & Pedro Pimentel-Nunes. (2017) Characterization of liver changes in ZSF1 rats, an animal model of metabolic syndrome. Revista Española de Enfermedades Digestivas 109.
Crossref
Kasi C. McPherson, Lateia Taylor, Ashley C. Johnson, Sean P. Didion, Aron M. Geurts, Michael R. Garrett & Jan M. Williams. (2016) Early development of podocyte injury independently of hyperglycemia and elevations in arterial pressure in nondiabetic obese Dahl SS leptin receptor mutant rats. American Journal of Physiology-Renal Physiology 311:4, pages F793-F804.
Crossref
M. Nusrat Sharif, Gabriela Campanholle, Eva E. Nagiec, Ju Wang, Jameel Syed, Shawn P. O’Neil, Yutian Zhan, Karrie Brenneman, Bruce Homer, Hendrik Neubert, Riyez Karim, Nick Pullen, Steven M. Evans, Margaret Fleming, Priya Chockalingam & Lih-Ling Lin. (2016) Soluble Fn14 Is Detected and Elevated in Mouse and Human Kidney Disease. PLOS ONE 11:5, pages e0155368.
Crossref
Christian G.M. van DijkNynke R. OosterhuisYan Juan XuMaarten BrandtWalter J. PaulusLoek van HeerebeekDirk J. DunckerMarianne C. VerhaarDulce FontouraAndré P. LourençoAdelino F. Leite-MoreiraInês Falcão-PiresJaap A. JolesCaroline Cheng. (2016) Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome. Circulation: Heart Failure 9:4.
Crossref
G. Conceição, I. Heinonen, A. P. Lourenço, D. J. Duncker & I. Falcão-Pires. (2016) Animal models of heart failure with preserved ejection fraction. Netherlands Heart Journal 24:4, pages 275-286.
Crossref
Yen-Chun LaiDiana M. TabimaJohn J. DubeKara S. HughanRebecca R. VanderpoolDmitry A. GoncharovClaudette M. St. CroixAdolfo Garcia-OcañaElena A. GoncharovaStevan P. TofovicAna L. MoraMark T. Gladwin. (2016) SIRT3–AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction. Circulation 133:8, pages 717-731.
Crossref
S. P. Tofovic, E. M. Salah, G. J. Smits, E. T. Whalley, B. Ticho, A. Deykin & E. K. Jackson. (2015) Dual A1/A2B Receptor Blockade Improves Cardiac and Renal Outcomes in a Rat Model of Heart Failure with Preserved Ejection Fraction. Journal of Pharmacology and Experimental Therapeutics 356:2, pages 333-340.
Crossref
Zhi Su, Deborah Widomski, Ji Ma, Marian Namovic, Arthur Nikkel, Laura Leys, Lauren Olson, Katherine Salte, Diana Donnelly-Roberts, Timothy Esbenshade & Steve McGaraughty. (2016) Longitudinal Changes in Measured Glomerular Filtration Rate, Renal Fibrosis and Biomarkers in a Rat Model of Type 2 Diabetic Nephropathy. American Journal of Nephrology 44:5, pages 339-353.
Crossref
Aaron J. PolichnowskiHector Licea-VargasMaria Picken, Jianrui Long, Rashmi BislaGeoffrey A. Williamson, Anil K. Bidani & Karen A. Griffin. (2015) Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy. American Journal of Physiology-Renal Physiology 309:9, pages F791-F799.
Crossref
Andrea Babelova, Birgitta C. Burckhardt, Gabriela Salinas-Riester, Claudia Pommerenke, Gerhard Burckhardt & Maja Henjakovic. (2015) Next generation sequencing of sex-specific genes in the livers of obese ZSF1 rats. Genomics 106:4, pages 204-213.
Crossref
Andrea Babelova, Birgitta C. Burckhardt, Waja Wegner, Gerhard Burckhardt & Maja Henjakovic. (2015) Sex-Differences in Renal Expression of Selected Transporters and Transcription Factors in Lean and Obese Zucker Spontaneously Hypertensive Fatty Rats. Journal of Diabetes Research 2015, pages 1-10.
Crossref
Goro Katsuura, Namiko Kawamura, Miyuki Nishida, Haruka Amitani, Akihiro Asakawa & Akio Inui. 2014. Molecular Mechanisms Underpinning the Development of Obesity. Molecular Mechanisms Underpinning the Development of Obesity 153 166 .
Rusty Kelley, Andrew Bruce, Tom Spencer, Eric Werdin, Roger Ilagan, Sumana Choudhury, Elias Rivera, Shay Wallace, Kelly Guthrie, Manuel Jayo, Fengfeng Xu, Anjali N. Rao, Benjamin D. Humphreys, Sharon Presnell & Tim Bertram. (2013) A Population of Selected Renal Cells Augments Renal Function and Extends Survival in the ZSF1 Model of Progressive Diabetic Nephropathy. Cell Transplantation 22:6, pages 1023-1039.
Crossref
Lyne Fellmann, Alessandro R. Nascimento, Eduardo Tibiriça & Pascal Bousquet. (2013) Murine models for pharmacological studies of the metabolic syndrome. Pharmacology & Therapeutics 137:3, pages 331-340.
Crossref
Victor P Bilan, Eman M Salah, Sheldon Bastacky, Huw B Jones, Rachel M Mayers, Bradley Zinker, Simon M Poucher & Stevan P Tofovic. (2011) Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats. Journal of Endocrinology 210:3, pages 293-308.
Crossref
Hannah SongPeter W. ZandstraMilica Radisic. (2011) Engineered Heart Tissue Model of Diabetic Myocardium. Tissue Engineering Part A 17:13-14, pages 1869-1878.
Crossref
Sharon C. PresnellAndrew T. BruceShay M. WallaceSumana ChoudhuryChristopher W. GenheimerBryan CoxKelly GuthrieEric S. WerdinPatricia Tatsumi-FichtRoger M. IlaganRussell W. KelleyElias A. RiveraJohn W. LudlowBelinda J. WagnerManuel J. JayoTimothy A. Bertram. (2011) Isolation, Characterization, and Expansion Methods for Defined Primary Renal Cell Populations from Rodent, Canine, and Human Normal and Diseased Kidneys. Tissue Engineering Part C: Methods 17:3, pages 261-273.
Crossref
Anookh Mohanan, Ram Gupta, Amita Dubey, Vikrant Jagtap, Appaji Mandhare, Ramesh C. Gupta, Vijay Chauthaiwale & Chaitanya Dutt. (2011) TRC120038, a Novel Dual AT 1 /ET A Receptor Blocker for Control of Hypertension, Diabetic Nephropathy, and Cardiomyopathy in ob-ZSF1 Rats . International Journal of Hypertension 2011, pages 1-12.
Crossref
Deepa Joshi, Ram Gupta, Amita Dubey, Ajay Shiwalkar, Padmaja Pathak, Ramesh C Gupta, Vijay Chauthaiwale & Chaitanya Dutt. (2009) TRC4186, a Novel AGE-breaker, Improves Diabetic Cardiomyopathy and Nephropathy in Ob-ZSF1 Model of Type 2 Diabetes. Journal of Cardiovascular Pharmacology 54:1, pages 72-81.
Crossref
Gregor Jost, Hubertus Pietsch, Janine Sommer, Peter Sandner, Philipp Lengsfeld, Peter Seidensticker, Stephan Lehr, Joachim Hütter & Martin A. Sieber. (2009) Retention of Iodine and Expression of Biomarkers for Renal Damage in the Kidney After Application of Iodinated Contrast Media in Rats. Investigative Radiology 44:2, pages 114-123.
Crossref
Olga Rafikova, Eman M. Salah & Stevan P. Tofovic. (2008) Renal and metabolic effects of tempol in obese ZSF1 rats—distinct role for superoxide and hydrogen peroxide in diabetic renal injury. Metabolism 57:10, pages 1434-1444.
Crossref
Sharma Prabhakar, Joel Starnes, Shuping Shi, Betty Lonis & Ruc Tran. (2007) Diabetic Nephropathy Is Associated with Oxidative Stress and Decreased Renal Nitric Oxide Production. Journal of the American Society of Nephrology 18:11, pages 2945-2952.
Crossref
Karen A. Griffin, Mohammad Abu-Naser, Isam Abu-Amarah, Maria Picken, Geoffrey A. Williamson & Anil K. Bidani. (2007) Dynamic blood pressure load and nephropathy in the ZSF1 ( fa / fa cp ) model of type 2 diabetes . American Journal of Physiology-Renal Physiology 293:5, pages F1605-F1613.
Crossref
Xinchen Zhang, Youhong Jia, Edwin K Jackson & Stevan P Tofovic. (2007) 2-Methoxyestradiol and 2-Ethoxyestradiol Retard the Progression of Renal Disease in Aged, Obese, Diabetic ZSF1 Rats. Journal of Cardiovascular Pharmacology 49:1, pages 56-63.
Crossref
Dwight R. Owens. 2006. The Laboratory Rat. The Laboratory Rat 711 732 .
Stevan P Tofovic, Eman M Salah, Raghvendra K Dubey, Mona F Melhem & Edwin K Jackson. (2005) Estradiol Metabolites Attenuate Renal and Cardiovascular Injury Induced by Chronic Nitric Oxide Synthase Inhibition. Journal of Cardiovascular Pharmacology 46:1, pages 25-35.
Crossref
Ki-Yoon Jung, Dana Dean, Jing Jiang, Susan Gaylor, William H Griffith, Robert C Burghardt & Alan R Parrish. (2004) Loss of N-cadherin and α-catenin in the proximal tubules of aging male Fischer 344 rats. Mechanisms of Ageing and Development 125:6, pages 445-453.
Crossref
Stevan P. Tofovic, Raghvendra Dubey, Eman M. Salah & Edwin K. Jackson. (2002) 2-Hydroxyestradiol Attenuates Renal Disease in Chronic Puromycin Aminonucleoside Nephropathy. Journal of the American Society of Nephrology 13:11, pages 2737-2747.
Crossref
Stevan P. Tofovic, Curtis K. KostJrJr, Edwin K. Jackson & Sheldon I. Bastacky. (2002) Long-term caffeine consumption exacerbates renal failure in obese, diabetic, ZSF1 (fa-facp) rats. Kidney International 61:4, pages 1433-1444.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.